Catalent | CTLT - هزینه بهره بدهی



هزینه بهره بدهی تغییر دادن تاریخ
Agilent USD 25M 2M 2025-12
AstraZeneca USD 484M 181M 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Bruker USD 20M 4.3M 2025-09
Centene USD 168M 2M 2025-12
Charles River Laboratories USD 23.78M 1.63M 2025-12
Cigna USD 157.92B 460K 2025-12
Danaher USD 55M 12M 2025-12
Dentsply International USD 22M 1000K 2025-12
Elevance Health USD 366M 15M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Glaxosmithkline GBP 177.95M 6.05M 2025-09
Hologic USD 27.6M 1000K 2025-12
Humana USD 146M 22M 2025-12
Illumina USD 25M 0 2025-09
Intuitive Surgical USD 19.35B 811.4M 2025-09
IQVIA Holdings USD 193M 4M 2025-12
J&J USD 18M 290M 2025-09
Laboratory Of America USD 55M 1000K 2025-12
Lonza CHF 84M 14M 2025-06
McKesson USD 63M 11M 2025-12
Merck EUR 121M 5M 2025-12
Merck USD 412M 85M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
Thermo Fisher Scientific USD 365M 18M 2025-12
UnitedHealth USD 974M 29M 2025-12
Veradigm USD 1.25M 641K 2022-09
Waters USD 8.62M 18.02M 2025-12
West Pharmaceutical Services USD 200K 100K 2025-09